Options expected to have increasing volume: BP BA AKAM THC CGNX EEFI

Go back to Options expected to have increasing volume: BP BA AKAM THC CGNX EEFI

Tenet Healthcare (THC) PT Raised to $30 at RBC Capital

May 2, 2018 8:45 AM EDT

RBC Capital raised its price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $21.00) while maintaining a Sector Perform rating.

Analyst Frank Morgan commented, "THC exceeded expectations and the high end of guidance for 1Q18, largely driven by outperformance at Conifer through accelerated cost... More